Clinical trials for the AstraZeneca vaccine resume
Clinical trials of the coronavirus vaccine by AstraZeneca and the University of Oxford have resumed.
The “green light” was given by the British Health Regulatory Authority, noting that it was now safe for the tests to proceed, the company announced on Saturday.
It is recalled that on Tuesday the company had announced the suspension of the tests, as one of the volunteers who took part had a serious side effect.
Saturday’s statement from AstraZeneca said the independent U.K. investigation into the event has concluded and it advised the Medicines Health Regulatory Authority, Britain’s equivalent of the Food and Drug Administration, that it was safe to resume the trial. The MHRA concurred and gave the green light for the trial to restart.
“The Company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic,” the spokesperson, Michele Meixell, wrote in an email.
You may be interested
Mitsotakis: Masks everywhere & curfew at night in the “orange” & “red” areas of the countrymakis - Oct 22, 2020
The obligatory use of a mask everywhere was announced by the Prime Minister Kyriakos Mitsotakis as the first measure to…
Coronavirus Greece: Explosive rise with 865 new cases, 331 in Attica & 181 in Thessalonikimakis - Oct 21, 2020
The Greek authorities announced today 865 new cases of coronavirus in the country, of which 82 are associated with known…